An improved nonisotopic test to screen a large series of new inhibitor molecules of poly(ADP-ribose) polymerase activity for therapeutic applications

Citation
P. Decker et al., An improved nonisotopic test to screen a large series of new inhibitor molecules of poly(ADP-ribose) polymerase activity for therapeutic applications, CLIN CANC R, 5(5), 1999, pp. 1169-1172
Citations number
34
Categorie Soggetti
Oncology
Journal title
CLINICAL CANCER RESEARCH
ISSN journal
10780432 → ACNP
Volume
5
Issue
5
Year of publication
1999
Pages
1169 - 1172
Database
ISI
SICI code
1078-0432(199905)5:5<1169:AINTTS>2.0.ZU;2-V
Abstract
A reliable ELISA for screening large numbers of poly(ADP-ribose) polymerase (PARP) inhibitors is described, The test is based upon the drop in PARP ac tivity estimated by the decrease in poly(ADP-ribose) synthesis in the prese nce of inhibitor. This ELISA is easy to perform, rapid, and specific. It is extremely sensitive because a clear inhibition of the total reaction could be visualized with molecules used in the nanomolar range. The assay uses n o radioactivity, and automation is possible with robots for large-scale inv estigations. This test is of great interest for the screening of chemical l ibraries and the discovery of new inhibitors (and possibly activators) of P ARP, Such molecules have important applications in all abnormal situations involving DNA damage and oxidative stress, such as cancer, autoimmunity, di abetes, myocardial dysfunctions, certain infections, aging, and radiation/c hemical exposure.